Martin O Weickert
Overview
Explore the profile of Martin O Weickert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
139
Citations
3157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kabisch S, Hajir J, Sukhobaevskaia V, Weickert M, Pfeiffer A
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076626
Cohort studies consistently show that a high intake of cereal fiber and whole-grain products is associated with a decreased risk of type 2 diabetes (T2DM), cancer, and cardiovascular diseases. Similar...
2.
Barber T, Kabisch S, Pfeiffer A, Weickert M
Metabolites
. 2025 Feb;
15(2).
PMID: 39997710
The 'Body Mass Index' (BMI) is an anachronistic and outdated ratio that is used as an internationally accepted diagnostic criterion for obesity, and to prioritise, stratify, and outcome-assess its management...
3.
Weickert M
Neuroendocrinology
. 2025 Feb;
:1-22.
PMID: 39938507
Background: Neuroendocrine neoplasms (NENs) are comparatively rare tumours. However, prevalence is increasing steeply, related to rising incidence, earlier detection, and prolonged survival in many cases of metastatic NENs, with implications...
4.
Clement D, van Leerdam M, Tesselaar M, Srinivasan P, Menon K, Kuhlmann K, et al.
Nutrients
. 2024 Nov;
16(22).
PMID: 39599579
Sarcopenia is a muscle disease that occur across a lifetime. It is commonly described in the aging population but can occur earlier in life in patients with cancer. Previous studies...
5.
Barber T, Kabisch S, Pfeiffer A, Weickert M
Nutrients
. 2024 Aug;
16(16).
PMID: 39203850
The prevalence of obesity globally has tripled over the last half century, and currently affects around 650 million adults and 340 million children and adolescents (ages 5-19 years). Obesity contributes...
6.
Daskalakis K, Tsoli M, Wedin M, Kos-Kudla B, Kogut A, Srirajaskanthan R, et al.
Neuroendocrinology
. 2024 Aug;
:1-9.
PMID: 39191217
Introduction: The purpose of this study was to evaluate longitudinal changes in Ki-67 indices of SI-NETs and assess the impact of these in overall survival (OS). Methods: We screened 551...
7.
Meyer N, Kabisch S, Dambeck U, Honsek C, Kemper M, Gerbracht C, et al.
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38928106
Lifestyle interventions can prevent type 2 diabetes (T2DM). However, some individuals do not experience anticipated improvements despite weight loss. Biomarkers to identify such individuals at early stages are lacking. Insulin-like...
8.
Griffen C, Cullen T, Hattersley J, Weickert M, Dallaway A, Duncan M, et al.
Exp Gerontol
. 2024 Jun;
193:112477.
PMID: 38844183
Purpose: Ageing is associated with cognitive decline. This study investigated the individual and combined effects of resistance exercise (RE) and whey protein supplementation (PRO) on cognitive function in older men....
9.
Khan M, Cook K, Weickert M, Davies L, Pritchard D, Day M, et al.
Support Care Cancer
. 2024 Feb;
32(3):199.
PMID: 38421441
Purpose: PREF-NET reported patients' experience of Somatuline® (lanreotide) Autogel® (LAN) administration at home and in hospital among patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs). Methods: PREF-NET was a multicentre, cross-sectional study...
10.
Daskalakis K, Tsoli M, Wallin G, Kogut A, Srirajaskanthan R, Harlow C, et al.
J Clin Endocrinol Metab
. 2024 Feb;
109(12):e2222-e2230.
PMID: 38415861
Context: One of the major prognostic indices in neuroendocrine tumors (NETs) is Ki67 proliferation index. Objective: To identify optimal grading Ki67 cutoffs to delineate differences in prognosis of patients with...